Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]
BJU International, 06/15/2012
Trivedi D et al. – Identifying men with erectile dysfunction (ED) provides an opportunity to modify future cardiovascular risk and to improve male ED–specific quality of life (MED–QoL) by treating them with 40 mg of simvastatin. The joint analysis of costs and quality–adjusted life year benefits suggests that there is high probability that simvastatin is a cost–effective strategy in men with ED. The findings could influence urological and primary care practice by including questions on ED during routine consultations and relevant clinical protocols. This provides an opportunity to impart lifestyle advice.